Cargando…

Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.

Phthalates are a group of industrial chemicals with many commercial uses, such as solvents, additives, and plasticizers. For example, di-(2-ethylhexyl) phthalate (DEHP) is added in varying amounts to certain plastics, such as polyvinyl chloride, to increase their flexibility. In humans, phthalates a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barr, Dana B, Silva, Manori J, Kato, Kayoko, Reidy, John A, Malek, Nicole A, Hurtz, Donald, Sadowski, Melissa, Needham, Larry L, Calafat, Antonia M
Formato: Texto
Lenguaje:English
Publicado: 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241566/
https://www.ncbi.nlm.nih.gov/pubmed/12842765
_version_ 1782125443938254848
author Barr, Dana B
Silva, Manori J
Kato, Kayoko
Reidy, John A
Malek, Nicole A
Hurtz, Donald
Sadowski, Melissa
Needham, Larry L
Calafat, Antonia M
author_facet Barr, Dana B
Silva, Manori J
Kato, Kayoko
Reidy, John A
Malek, Nicole A
Hurtz, Donald
Sadowski, Melissa
Needham, Larry L
Calafat, Antonia M
author_sort Barr, Dana B
collection PubMed
description Phthalates are a group of industrial chemicals with many commercial uses, such as solvents, additives, and plasticizers. For example, di-(2-ethylhexyl) phthalate (DEHP) is added in varying amounts to certain plastics, such as polyvinyl chloride, to increase their flexibility. In humans, phthalates are metabolized to their respective monoesters, conjugated, and eliminated. However, despite the high production and use of DEHP, we have recently found that the urinary levels of the DEHP metabolite mono-(2-ethylhexyl) phthalate (MEHP) in 2,541 persons in the United States were lower than we anticipated, especially when compared with urinary metabolite levels of other commonly used phthalates. This finding raised questions about the sensitivity of this biomarker for assessing DEHP exposure. We explored the utility of two other DEHP metabolites, mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), as additional DEHP biomarkers. These metabolites are formed by oxidative metabolism of MEHP. In urine from 62 people, both the range and the mean urinary levels of MEOHP and MEHHP were on average 4-fold higher than those of MEHP; the mean of the individual ratios of MEHHP/MEOHP, MEHHP/MEHP, and MEOHP/MEHP were 1.4, 8.2, and 5.9, respectively. These data suggest that MEOHP and MEHHP are more sensitive biomarkers of exposure to DEHP than is MEHP. These findings also suggest a predominant human metabolic route for DEHP hydrolysis to MEHP followed by oxidation of MEHP; they also imply that a similar mechanism may be relevant for other high-molecular-weight phthalates, such as di-n-octyl, di-isononyl, and di-isodecyl phthalates.
format Text
id pubmed-1241566
institution National Center for Biotechnology Information
language English
publishDate 2003
record_format MEDLINE/PubMed
spelling pubmed-12415662005-11-08 Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Barr, Dana B Silva, Manori J Kato, Kayoko Reidy, John A Malek, Nicole A Hurtz, Donald Sadowski, Melissa Needham, Larry L Calafat, Antonia M Environ Health Perspect Research Article Phthalates are a group of industrial chemicals with many commercial uses, such as solvents, additives, and plasticizers. For example, di-(2-ethylhexyl) phthalate (DEHP) is added in varying amounts to certain plastics, such as polyvinyl chloride, to increase their flexibility. In humans, phthalates are metabolized to their respective monoesters, conjugated, and eliminated. However, despite the high production and use of DEHP, we have recently found that the urinary levels of the DEHP metabolite mono-(2-ethylhexyl) phthalate (MEHP) in 2,541 persons in the United States were lower than we anticipated, especially when compared with urinary metabolite levels of other commonly used phthalates. This finding raised questions about the sensitivity of this biomarker for assessing DEHP exposure. We explored the utility of two other DEHP metabolites, mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) and mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), as additional DEHP biomarkers. These metabolites are formed by oxidative metabolism of MEHP. In urine from 62 people, both the range and the mean urinary levels of MEOHP and MEHHP were on average 4-fold higher than those of MEHP; the mean of the individual ratios of MEHHP/MEOHP, MEHHP/MEHP, and MEOHP/MEHP were 1.4, 8.2, and 5.9, respectively. These data suggest that MEOHP and MEHHP are more sensitive biomarkers of exposure to DEHP than is MEHP. These findings also suggest a predominant human metabolic route for DEHP hydrolysis to MEHP followed by oxidation of MEHP; they also imply that a similar mechanism may be relevant for other high-molecular-weight phthalates, such as di-n-octyl, di-isononyl, and di-isodecyl phthalates. 2003-07 /pmc/articles/PMC1241566/ /pubmed/12842765 Text en
spellingShingle Research Article
Barr, Dana B
Silva, Manori J
Kato, Kayoko
Reidy, John A
Malek, Nicole A
Hurtz, Donald
Sadowski, Melissa
Needham, Larry L
Calafat, Antonia M
Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
title Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
title_full Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
title_fullStr Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
title_full_unstemmed Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
title_short Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
title_sort assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241566/
https://www.ncbi.nlm.nih.gov/pubmed/12842765
work_keys_str_mv AT barrdanab assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT silvamanorij assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT katokayoko assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT reidyjohna assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT maleknicolea assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT hurtzdonald assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT sadowskimelissa assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT needhamlarryl assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers
AT calafatantoniam assessinghumanexposuretophthalatesusingmonoestersandtheiroxidizedmetabolitesasbiomarkers